MedTrace Logo

Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center

NCT06056349 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-05-31

No results posted yet for this study

Summary

The aim of this study is to determine the efficacy in seizure reduction when comparing orodispersable clonazepam versus usual treatment (i.e. medication load, intravenous high- dose benzodiazepines) of seizure clusters in a third level center of care in Mexico city.

Conditions

  • Cluster Seizure

Interventions

DRUG

Midazolam oral solution

Buccal administration

DRUG

ClonazePAM Oral Product

Orodispersable

OTHER

Usual medication/ traditional

Medication that is usually used in the emergency department

Sponsors & Collaborators

  • El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

    lead OTHER

Principal Investigators

  • Elma M Paredes-Aragón, MD · National Institute of Neurology and Neurosurgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06056349 on ClinicalTrials.gov